Page 158 - Haematologica Vol. 110 - January 2025
P. 158
ARTICLE - R-GemOx+Atezo in R/R transformed DLBCL A
T. Othman et al.
Figure 3. Survival outcomes in patients treated with rituximab, gemcitabine, ox- aliplatin, and atezolizumab. (A) Progres- sion-free and overall survival for all treat- ed patients. (B) Progression-free survival for patients with follicular lymphoma or non-follicular lymphoma. (C) Overall sur- vival for patients with follicular lymphoma or non-follicular lymphoma. 95% CI: 95% confidence interval; NR: not reached.
B
C
Haematologica | 110 January 2025
150
